RISE CAB training package
Skip to content

The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection. They are intended to provide a PrEP-specific resource for costing that could be accessible to individuals tasked with collecting, evaluating, and utilizing cost data, and who may have differing levels of familiarity with economics.

The PrEP Costing Guidelines have three principal aims: (1) Support the estimation of the full and incremental total cost and unit cost of adding PrEP to existing HIV or other health services; (2) Address some of the challenges faced by costing experts who are specifically assessing the costs of PrEP; and, (3) Improve the quality, interpretation and use of PrEP cost estimates through improved consistency and transparency of methods, assumptions and reporting.

Featured Resources